S&P 500   3,632.30 (-0.17%)
DOW   29,727.94 (-0.61%)
QQQ   299.40 (+0.13%)
AAPL   117.21 (+0.53%)
MSFT   214.79 (-0.20%)
FB   276.49 (-0.48%)
GOOGL   1,782.55 (-0.25%)
AMZN   3,202.20 (+0.21%)
TSLA   601.00 (+2.60%)
NVDA   530.45 (+0.00%)
BABA   268.45 (-2.90%)
CGC   28.95 (-0.17%)
GE   10.41 (+0.10%)
MU   64.31 (+0.12%)
AMD   87.47 (+0.32%)
T   28.95 (-0.28%)
NIO   53.73 (-0.50%)
F   9.23 (+1.54%)
ACB   11.14 (+6.40%)
NFLX   489.65 (-0.35%)
BA   216.13 (-0.17%)
GILD   59.75 (-0.47%)
DIS   146.77 (-0.24%)
S&P 500   3,632.30 (-0.17%)
DOW   29,727.94 (-0.61%)
QQQ   299.40 (+0.13%)
AAPL   117.21 (+0.53%)
MSFT   214.79 (-0.20%)
FB   276.49 (-0.48%)
GOOGL   1,782.55 (-0.25%)
AMZN   3,202.20 (+0.21%)
TSLA   601.00 (+2.60%)
NVDA   530.45 (+0.00%)
BABA   268.45 (-2.90%)
CGC   28.95 (-0.17%)
GE   10.41 (+0.10%)
MU   64.31 (+0.12%)
AMD   87.47 (+0.32%)
T   28.95 (-0.28%)
NIO   53.73 (-0.50%)
F   9.23 (+1.54%)
ACB   11.14 (+6.40%)
NFLX   489.65 (-0.35%)
BA   216.13 (-0.17%)
GILD   59.75 (-0.47%)
DIS   146.77 (-0.24%)
S&P 500   3,632.30 (-0.17%)
DOW   29,727.94 (-0.61%)
QQQ   299.40 (+0.13%)
AAPL   117.21 (+0.53%)
MSFT   214.79 (-0.20%)
FB   276.49 (-0.48%)
GOOGL   1,782.55 (-0.25%)
AMZN   3,202.20 (+0.21%)
TSLA   601.00 (+2.60%)
NVDA   530.45 (+0.00%)
BABA   268.45 (-2.90%)
CGC   28.95 (-0.17%)
GE   10.41 (+0.10%)
MU   64.31 (+0.12%)
AMD   87.47 (+0.32%)
T   28.95 (-0.28%)
NIO   53.73 (-0.50%)
F   9.23 (+1.54%)
ACB   11.14 (+6.40%)
NFLX   489.65 (-0.35%)
BA   216.13 (-0.17%)
GILD   59.75 (-0.47%)
DIS   146.77 (-0.24%)
S&P 500   3,632.30 (-0.17%)
DOW   29,727.94 (-0.61%)
QQQ   299.40 (+0.13%)
AAPL   117.21 (+0.53%)
MSFT   214.79 (-0.20%)
FB   276.49 (-0.48%)
GOOGL   1,782.55 (-0.25%)
AMZN   3,202.20 (+0.21%)
TSLA   601.00 (+2.60%)
NVDA   530.45 (+0.00%)
BABA   268.45 (-2.90%)
CGC   28.95 (-0.17%)
GE   10.41 (+0.10%)
MU   64.31 (+0.12%)
AMD   87.47 (+0.32%)
T   28.95 (-0.28%)
NIO   53.73 (-0.50%)
F   9.23 (+1.54%)
ACB   11.14 (+6.40%)
NFLX   489.65 (-0.35%)
BA   216.13 (-0.17%)
GILD   59.75 (-0.47%)
DIS   146.77 (-0.24%)
Log in
NASDAQ:GNMK

GenMark Diagnostics News Headlines

$12.95
+0.53 (+4.27 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$12.42
Now: $12.95
$13.20
50-Day Range
$11.09
MA: $12.72
$14.30
52-Week Range
$3.36
Now: $12.95
$20.88
Volume14,992 shs
Average Volume1.86 million shs
Market Capitalization$928.79 million
P/E RatioN/A
Dividend YieldN/A
Beta3.23

Headlines

GenMark Diagnostics (NASDAQ GNMK) News Headlines Today

Source:
SourceHeadline
ValuEngine Downgrades GenMark Diagnostics (NASDAQ:GNMK) to HoldValuEngine Downgrades GenMark Diagnostics (NASDAQ:GNMK) to Hold
marketbeat.com - November 10 at 1:24 AM
GenMark Diagnostics (GNMK) Buy Rating Reiterated at Canaccord GenuityGenMark Diagnostics' (GNMK) Buy Rating Reiterated at Canaccord Genuity
marketbeat.com - October 29 at 2:07 AM
GenMark Receives FDA Nod, Guides Revenue Higher—But Stock Gets Cheaper GenMark Receives FDA Nod, Guides Revenue Higher—But Stock Gets Cheaper
marketbeat.com - October 12 at 4:25 PM
GenMark Diagnostics (NASDAQ:GNMK) Lifted to "Hold" at BidaskClubGenMark Diagnostics (NASDAQ:GNMK) Lifted to "Hold" at BidaskClub
marketbeat.com - September 15 at 1:23 AM
Pullback in GenMark Diagnostics Gives Investors Another Chance (GNMK)Pullback in GenMark Diagnostics Gives Investors Another Chance (GNMK)
marketbeat.com - August 17 at 6:32 PM
GenMark Diagnostics (NASDAQ:GNMK) Stock Rating Lowered by BidaskClubGenMark Diagnostics (NASDAQ:GNMK) Stock Rating Lowered by BidaskClub
marketbeat.com - August 11 at 6:27 AM
Scott Mendel Sells 5,190 Shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) StockScott Mendel Sells 5,190 Shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) Stock
americanbankingnews.com - November 25 at 9:00 PM
Dont Ignore The Fact That This Insider Just Sold Some Shares In GenMark Diagnostics, Inc. (NASDAQ:GNMK)Don't Ignore The Fact That This Insider Just Sold Some Shares In GenMark Diagnostics, Inc. (NASDAQ:GNMK)
nasdaq.com - November 23 at 8:15 AM
GenMark Diagnostics, Inc. (NASDAQ:GNMK) VP Alan Baer Maderazo Sells 1,310 SharesGenMark Diagnostics, Inc. (NASDAQ:GNMK) VP Alan Baer Maderazo Sells 1,310 Shares
americanbankingnews.com - November 20 at 9:06 PM
GenMark Diagnostics, Inc. (NASDAQ:GNMK) SVP Michael Gleeson Sells 1,637 SharesGenMark Diagnostics, Inc. (NASDAQ:GNMK) SVP Michael Gleeson Sells 1,637 Shares
americanbankingnews.com - November 20 at 9:06 PM
Scott Mendel Sells 3,987 Shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) StockScott Mendel Sells 3,987 Shares of GenMark Diagnostics, Inc. (NASDAQ:GNMK) Stock
americanbankingnews.com - November 20 at 9:06 PM
Insider Selling: GenMark Diagnostics, Inc. (NASDAQ:GNMK) SVP Sells 59,293 Shares of StockInsider Selling: GenMark Diagnostics, Inc. (NASDAQ:GNMK) SVP Sells 59,293 Shares of Stock
americanbankingnews.com - November 13 at 6:35 PM
GenMark Diagnostics (NASDAQ:GNMK) Trading 10.1% Higher GenMark Diagnostics (NASDAQ:GNMK) Trading 10.1% Higher
americanbankingnews.com - November 11 at 7:21 PM
GenMark Diagnostics (NASDAQ:GNMK) Shares Gap Down to $13.84GenMark Diagnostics (NASDAQ:GNMK) Shares Gap Down to $13.84
americanbankingnews.com - November 9 at 10:08 AM
GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics ForumGenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum
finance.yahoo.com - November 5 at 7:51 PM
GenMark Diagnostics, Inc. (NASDAQ:GNMK) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their EstimatesGenMark Diagnostics, Inc. (NASDAQ:GNMK) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
finance.yahoo.com - October 30 at 9:25 AM
GenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q3 2020 Results - Earnings Call TranscriptGenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - October 28 at 11:53 PM
GenMark Diagnostics, Inc. to Host Earnings CallGenMark Diagnostics, Inc. to Host Earnings Call
finance.yahoo.com - October 28 at 6:52 PM
GenMark Diagnostics Reports Third Quarter 2020 ResultsGenMark Diagnostics Reports Third Quarter 2020 Results
finance.yahoo.com - October 28 at 6:52 PM
FDA grants emergency clearance for GenMark test that screens for the flu, coronavirus and other virusesFDA grants emergency clearance for GenMark test that screens for the flu, coronavirus and other viruses
cnbc.com - October 9 at 12:41 PM
GenMark Gains on FiguresGenMark Gains on Figures
baystreet.ca - October 9 at 12:41 PM
Stocks making the biggest moves after hours: GenMark Diagnostics, Nvidia, Zoom Video & moreStocks making the biggest moves after hours: GenMark Diagnostics, Nvidia, Zoom Video & more
cnbc.com - October 8 at 7:55 PM
GenMark sees 104% jump in Q3 salesGenMark sees 104% jump in Q3 sales
seekingalpha.com - October 8 at 7:55 PM
GenMark Diagnostics EPlex Respiratory Pathogen Panel 2 Gets Emergency Use AuthorizationGenMark Diagnostics' EPlex Respiratory Pathogen Panel 2 Gets Emergency Use Authorization
nasdaq.com - October 8 at 7:55 PM
Innovative Devices Help Ease the Burden of Tracking DiseasesInnovative Devices Help Ease the Burden of Tracking Diseases
marketwatch.com - September 23 at 12:02 PM
Milestone Pharmaceuticals Strengthens Board of Directors with Two New AppointmentsMilestone Pharmaceuticals Strengthens Board of Directors with Two New Appointments
finance.yahoo.com - September 22 at 8:48 AM
GenMark Diagnostics Inc.GenMark Diagnostics Inc.
marketwatch.com - September 17 at 12:49 AM
Are Options Traders Betting on a Big Move in GenMark Diagnostics (GNMK) Stock?Are Options Traders Betting on a Big Move in GenMark Diagnostics (GNMK) Stock?
finance.yahoo.com - September 16 at 2:47 PM
GenMark Diagnostics, Inc.: GenMark Diagnostics ePlex Respiratory Pathogen Panel 2 (RP2) achieves CE MarkGenMark Diagnostics, Inc.: GenMark Diagnostics' ePlex Respiratory Pathogen Panel 2 (RP2) achieves CE Mark
finanznachrichten.de - September 14 at 6:07 PM
GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE MarkGenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark
finance.yahoo.com - September 14 at 6:07 PM
Breakeven On The Horizon For GenMark Diagnostics, Inc. (NASDAQ:GNMK)Breakeven On The Horizon For GenMark Diagnostics, Inc. (NASDAQ:GNMK)
finance.yahoo.com - September 7 at 2:46 PM
Genmark Diagnostics Inc (GNMK) President & CEO Scott Mendel Sold $751,000 of SharesGenmark Diagnostics Inc (GNMK) President & CEO Scott Mendel Sold $751,000 of Shares
finance.yahoo.com - August 28 at 10:56 PM
First Week of April 2021 Options Trading For GenMark Diagnostics (GNMK)First Week of April 2021 Options Trading For GenMark Diagnostics (GNMK)
nasdaq.com - August 21 at 2:48 PM
Tracon FDA Clearance, And Other News: The Good, Bad And Ugly Of BiopharmaTracon FDA Clearance, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - August 18 at 11:58 PM
Genmark Diagnostics Inc (GNMK) CFO John Frederick Ek Sold $533,364 of SharesGenmark Diagnostics Inc (GNMK) CFO John Frederick Ek Sold $533,364 of Shares
finance.yahoo.com - August 18 at 11:58 PM
GenMark up 8% on emergency use application for SARS-CoV-2 testGenMark up 8% on emergency use application for SARS-CoV-2 test
seekingalpha.com - August 17 at 9:11 AM
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 TestGenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test
finance.yahoo.com - August 17 at 9:11 AM
GenMark Diagnostics Inc (GNMK) Q2 2020 Earnings Call TranscriptGenMark Diagnostics Inc (GNMK) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 13 at 4:28 AM
GenMark: Near-Term Capital Gain Prospects From COVID-19 Testing RaceGenMark: Near-Term Capital Gain Prospects From COVID-19 Testing Race
seekingalpha.com - August 6 at 8:06 PM
Diagnostics Begin to Play a Greater Role in the Fight Against CancerDiagnostics Begin to Play a Greater Role in the Fight Against Cancer
prnewswire.com - August 6 at 9:51 AM
GenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q2 2020 Results - Earnings Call TranscriptGenMark Diagnostics, Inc. (GNMK) CEO Scott Mendel on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 1:25 AM
GenMark Diagnostics EPS beats by $0.02, beats on revenueGenMark Diagnostics EPS beats by $0.02, beats on revenue
seekingalpha.com - August 4 at 8:25 PM
GenMark Diagnostics Reports Second Quarter 2020 ResultsGenMark Diagnostics Reports Second Quarter 2020 Results
finance.yahoo.com - August 4 at 8:25 PM
Recap: GenMark Diagnostics Q2 EarningsRecap: GenMark Diagnostics Q2 Earnings
finance.yahoo.com - August 4 at 8:25 PM
Is GenMark Diagnostics (NASDAQ:GNMK) Share Price Gain Of 186% Well Earned?Is GenMark Diagnostics' (NASDAQ:GNMK) Share Price Gain Of 186% Well Earned?
finance.yahoo.com - July 22 at 11:29 PM
Has GenMark Diagnostics (GNMK) Outpaced Other Medical Stocks This Year?Has GenMark Diagnostics (GNMK) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - July 22 at 1:27 PM
Is GenMark Diagnostics' (NASDAQ:GNMK) Share Price Gain Of 186% Well Earned?Is GenMark Diagnostics' (NASDAQ:GNMK) Share Price Gain Of 186% Well Earned?
finance.yahoo.com - July 22 at 1:27 PM
GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020
finance.yahoo.com - July 21 at 7:32 PM
GenMarks Shares March Higher, Can It Continue?GenMark's Shares March Higher, Can It Continue?
www.nasdaq.com - July 14 at 10:01 AM
GenMark's Shares March Higher, Can It Continue?GenMark's Shares March Higher, Can It Continue?
finance.yahoo.com - July 14 at 10:01 AM
GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go?GenMark Diagnostics (GNMK) Stock Is a Winner, But How Much Higher Can It Go?
finance.yahoo.com - July 10 at 12:02 AM
Stock Alert: GenMark Diagnostics Trading 15% Higher On Higher Revenue ExpectationsStock Alert: GenMark Diagnostics Trading 15% Higher On Higher Revenue Expectations
www.nasdaq.com - July 8 at 2:02 PM
Covid Report: Coronavirus Test Maker GenMark Diagnostics Jumps On Sales BeatCovid Report: Coronavirus Test Maker GenMark Diagnostics Jumps On Sales Beat
finance.yahoo.com - July 8 at 2:02 PM
GenMark Soaring In Pre-Market On 118% Revenue ExplosionGenMark Soaring In Pre-Market On 118% Revenue Explosion
finance.yahoo.com - July 8 at 8:57 AM
GenMark sees 118% jump in Q2 salesGenMark sees 118% jump in Q2 sales
seekingalpha.com - July 7 at 6:02 PM
GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020
finance.yahoo.com - July 7 at 6:02 PM
This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.